FAAH inhibition represents a mechanistically distinct and circuit-selective strategy to suppress absence seizures, likely through elevation of endogenous AEA and targeted modulation of thalamocortical networks. These findings support further translational development of FAAH inhibitors as potential therapies for CAE.
Morais et al. (Wed,) studied this question.